“Use of eculizumab in atypical hemolytic uremic syndrome associated with impaired renal function: integrative review”, Arch. Health. Sci, vol. 26, no. 1, pp. 72–75, Dec. 2022, doi: 10.17696/2318-3691.26.1.2019.1222.